DOCS vs TLRY
Doximity Inc (DOCS) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the DOCS and TLRY stock pages for the full models.
Not investment advice.